Literature DB >> 10206239

Genetic linkage study of panic: clinical methodology and description of pedigrees.

A J Fyer1, M M Weissman.   

Abstract

This paper describes the clinical methodology and currently collected pedigrees from an ongoing genetic study of panic disorder. The main objectives are to (1) document the clinical aspects of the study for current [Knowles et al., 1998: Am. J. Med. Genet. (Neuropsychiatr. Genet.) 81:138-147] and future reports of genetic analysis; (2) assist other investigators working on the genetic aspects of panic disorder who wish to compare results; and (3) illustrate the numerous judgment calls required in such studies that may lead to methodological variability and could account for differences in findings between studies. We also describe initial strategies to identify more genetically homogeneous panic disorder subtypes. Families were recruited through letters to magazines, word of mouth referral, and screening in anxiety disorder clinics and were asked to participate if at initial diagnostic screening they appeared to have at least three members (in two generations) affected with panic disorder. Diagnostic evaluations included a lifetime clinician-administered semistructured psychiatric interview, family history assessment, and pertinent medical records. Diagnoses for linkage analysis are derived from a best-estimate procedure that includes independent review of all materials by two senior investigators. All clinical evaluations were done blind to genotypes. Fifty-five pedigrees including 679 individuals have been collected to date. DNA is available from 500 family members of whom almost half (48%) are definitely or probably affected with panic disorder. Most (93%) of these subjects were directly interviewed, and the clinical data include not only lifetime psychiatric and medical diagnoses and but also detailed narrative histories describing sequence and context of symptoms. Family sizes range from 4-36 individuals (mean = 12.3) and the number of affected individuals per family from 2-12.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10206239

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  15 in total

1.  Linkage analysis of alternative anxiety phenotypes in multiply affected panic disorder families.

Authors:  Abby J Fyer; Ramiro Costa; Fatemeh Haghighi; Mark W Logue; James A Knowles; Myrna M Weissman; Susan E Hodge; Steven P Hamilton
Journal:  Psychiatr Genet       Date:  2012-06       Impact factor: 2.458

2.  A linkage search for joint panic disorder/bipolar genes.

Authors:  Mark W Logue; Martina Durner; Gary A Heiman; Susan E Hodge; Steven P Hamilton; James A Knowles; Abby J Fyer; Myrna M Weissman
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-12-05       Impact factor: 3.568

3.  Evidence for linkage and association of GABRB3 and GABRA5 to panic disorder.

Authors:  Laura M Hodges; Abby J Fyer; Myrna M Weissman; Mark W Logue; Fatemeh Haghighi; Oleg Evgrafov; Allessandro Rotondo; James A Knowles; Steven P Hamilton
Journal:  Neuropsychopharmacology       Date:  2014-05-23       Impact factor: 7.853

4.  The EPDS-Lifetime: assessment of lifetime prevalence and risk factors for perinatal depression in a large cohort of depressed women.

Authors:  Samantha Meltzer-Brody; Lynn Boschloo; Ian Jones; Patrick F Sullivan; Brenda W Penninx
Journal:  Arch Womens Ment Health       Date:  2013-08-01       Impact factor: 3.633

5.  A survey of putative anxiety-associated genes in panic disorder patients with and without bladder symptoms.

Authors:  Ryan L Subaran; Ardesheer Talati; Steven P Hamilton; Phillip Adams; Myrna M Weissman; Abby J Fyer; Susan E Hodge
Journal:  Psychiatr Genet       Date:  2012-12       Impact factor: 2.458

6.  Multivariate analysis of anxiety disorders yields further evidence of linkage to chromosomes 4q21 and 7p in panic disorder families.

Authors:  Mark W Logue; Sarah R Bauver; James A Knowles; Marc J Gameroff; Myrna M Weissman; Raymond R Crowe; Abby J Fyer; Steven P Hamilton
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2012-01-17       Impact factor: 3.568

7.  Further genetic evidence for a panic disorder syndrome mapping to chromosome 13q.

Authors:  Steven P Hamilton; Abby J Fyer; Martina Durner; Gary A Heiman; Ada Baisre de Leon; Susan E Hodge; James A Knowles; Myrna M Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-25       Impact factor: 11.205

8.  The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods.

Authors:  Brenda W J H Penninx; Aartjan T F Beekman; Johannes H Smit; Frans G Zitman; Willem A Nolen; Philip Spinhoven; Pim Cuijpers; Peter J De Jong; Harm W J Van Marwijk; Willem J J Assendelft; Klaas Van Der Meer; Peter Verhaak; Michel Wensing; Ron De Graaf; Witte J Hoogendijk; Johan Ormel; Richard Van Dyck
Journal:  Int J Methods Psychiatr Res       Date:  2008       Impact factor: 4.035

9.  Panic disorder, social anxiety disorder, and a possible medical syndrome previously linked to chromosome 13.

Authors:  Ardesheer Talati; Kathryn Ponniah; Lisa J Strug; Susan E Hodge; Abby J Fyer; Myrna M Weissman
Journal:  Biol Psychiatry       Date:  2007-10-24       Impact factor: 13.382

10.  Unstable maternal environment, separation anxiety, and heightened CO2 sensitivity induced by gene-by-environment interplay.

Authors:  Francesca R D'Amato; Claudio Zanettini; Valentina Lampis; Roberto Coccurello; Tiziana Pascucci; Rossella Ventura; Stefano Puglisi-Allegra; Chiara A M Spatola; Paola Pesenti-Gritti; Diego Oddi; Anna Moles; Marco Battaglia
Journal:  PLoS One       Date:  2011-04-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.